RASSF1 and gastric cancer: For GC patients, there was no significant heterogeneity between studies, and the combined HR (95% CI) in the fixed effects model indicated a significant positive correlation (P = 0.004) between RASSF1A methylation and GC prognosis (Figure 3(a)).